1 Min Read
April 28 (Reuters) - Oncocyte Corp
* Oncocyte continues to make progress towards commercialization; reports first quarter 2017 results
* Q1 loss per share $0.16 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.